Sign in Pull a receipt

AVLN

Avalyn Pharma Inc.

Healthcare · Biotechnology

$94.71 sample

+0.79 (+0.84%) 1D

Market cap

$400.8B

Price as of

2026-10-29

Latest filing

8-K · 2026-10-06

Alerts

8

Price$94.71 +13.71% 3M daily closessample

95.3679.75

2026-08-032026-08-252026-09-162026-10-072026-10-29

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 20INSInsider buy: 10% owner
Oct 13INSInsider sell: 10% owner
Oct 06SECDEF 14A filed
Sep 29INSInsider sell: Director
Sep 23SECDEF 14A filed
Sep 16SECDEF 14A filed
Sep 07INSInsider buy: Chief Financial Officer
Sep 01INSInsider sell: Chief Financial Officer

Sign up to see the real AVLN record →

Company facts

SEC EDGAR registration

Name: Avalyn Pharma Inc.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: -51sample, -100 to +100
Reporting currency: USD

Who is positioning in AVLN

sample

Insiders: 20 insider transactions over 90 days, net selling, $178.7M
Congress: 5 members traded over 90 days
Institutions · 13F: 25 funds hold $9.7B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$15.2B +12.8% y/y

Q4 2024Q3 2026

Inventory$9.5B +22.4% y/y

Q4 2024Q3 2026

Accounts receivable$7.0B +17.0% y/y

Q4 2024Q3 2026

Total debt$18.8B +10.2% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $272.9B +7.2% 3M
Sample peer B: $186.1B +3.5% 3M
Sample peer C: $357.5B -1.6% 3M
Sample peer D: $319.7B +10.1% 3M
Sample peer E: $346.4B +15.7% 3M